301. [Measurement of circulating 1,25-dihydroxyvitamin D employing radioimmunoassay]
- Author
-
I, Yamamoto, H, Hamazu, Y, Kigami, and R, Morita
- Subjects
Adult ,Male ,Binding Sites ,Sarcoidosis ,Hypoparathyroidism ,Hyperparathyroidism ,Radioimmunoassay ,Acute Kidney Injury ,Middle Aged ,Radioligand Assay ,Humans ,Calcium ,Female ,Vitamin D ,Aged - Abstract
Measurement of serum 1,25-dihydroxyvitamin D levels is important for diagnosis of various calcium metabolism disorders. Conventional assays for 1,25-dihydroxyvitamin D employed specific 1,25-dihydroxyvitamin D receptor as binding site for the ligand and thus, biologically active 1,25-dihydroxyvitamin D ligand, which is labeled with 3H, was required. Usage of 3H made assays cumbersome works. A new assay which uses specific antibody as the binding site and the radioligand labeled with 125I is now available as a commercial kit. Using these kits, we first studied basically the reproducibility, recovery, cross-reactivity and comparison with conventional assays. All of those results were satisfactory. Secondly, we measured clinically in 111 healthy adults and in patients with various disorders such as renal failure, primary hyperparathyroidism, hypoparathyroidism and sarcoidosis. This newly available kit for measurement of circulating 1,25-dihydroxyvitamin D is proved to be useful in clinical evaluation of calcium metabolic disorders.
- Published
- 1997